GlassScriptPhysician profile
David O Moore
NPI 1811985369
$3,554.17
in general payments reported to CMS, 2019-2025
18 companies · $418 in 2025
The $418 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,508 · 2020: $24.14 · 2021: $187 · 2022: $383 · 2023: $699 · 2024: $336 · 2025: $418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,452.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $1,280.93 | 2019-2023 | |
| W. L. Gore & Associates, INC. | $495.60 | 2021-2024 | Gore Tag Thoracic Branch Endoprosthesis |
| Davol INC. | $490.26 | 2023-2024 | Tridyne Vascular Sealant, Arista Ah Flexitip |
| Artivion, INC. | $364.29 | 2023-2025 | Cardiac Non-Synergraft, Cryovalve Sg Pulmonary Human Heart Valve |
| Bolton Medical INC | $198.26 | 2025 | Thoraflex Hybrid, Relay Thoracic Stent-Graft With Plus Delivery System |
| Edwards Lifesciences Corporation | $196.22 | 2019 | |
| Abbott Laboratories | $158.92 | 2021-2022 | |
| Abiomed | $129.96 | 2023 | Impella |
| Actelion Pharmaceuticals US, INC. | $35.35 | 2024 | Opsumit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $31.63 | 2019 | |
| La Jolla Pharmaceutical Company | $29.93 | 2019 | |
| Viz.Ai, INC. | $28.28 | 2022 | |
| Angiodynamics, INC. | $24.14 | 2020 | |
| Grifols USA, LLC | $20.76 | 2019 | |
| Medtronic, INC. | $19.10 | 2023 | Contour 3d |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $19.10 | 2025 | V.A.C.Ulta, Prevena |
| Kls-Martin L.P. | $16.67 | 2022 | |
| Medtronic Vascular, INC. | $14.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.